Diagnostics
Global High Intensity Focused Ultrasound (HIFU) Therapy Market (by Imaging Technology, Indication, Region, And End User), Company Profiles, Product Analysis & Recent Development - Forecast To 2030
The global high intensity focused ultrasound (HIFU) therapy market is predicted to reach US$ 310.5 Million by 2030. The oncology segment dominates the global HIFU therapy market, owing to increase in the use of HIFU devices for the treatment of various cancer types. In oncology, prostate cancer application dominates the high-intensity focused ultrasound (HIFU) therapy market.
Global Food Safety Testing Market (by Contaminants, Pathogens, Types Of Food Tested, Technology, Region), Company Profiles, Major Acquisitions And Recent Developments - Forecast To 2030
The global food safety testing market is predicted to reach US$ 35.3 Billion by 2030. The increasing consumption of processed and packaged food in developing and developed countries, owing to factors such as shifting lifestyles and food habits, rapid urbanization & fast paced life, increasing disposable incomes of consumers, rise in nuclear families and dual income households, is projected to drive the food safety testing market.Â
Global Drug Of Abuse Testing Market (By Product Type, Test Type, Drug Type, End Users, Region), Regulatory Status, Recent Developments, Company Profiles - Forecast To 2030
The global drug of abuse testing market is predicted to exceed US$ 8.0 Billion by 2030. The use of illicit drugs is increasing across the globe. According to the UNODC World Drug Report 2023, about 5.8 percent of the population aged between 15 and 64 years have used drugs at least once in the past year, while 39.5 million people worldwide were suffering from drug use disorders. Opioids account for 69% of deaths due to drug use disorders.Â
Global Autoimmune Disease Diagnostics Market (By Disease, Test Types, Region), Key Company Profiles, Strategy, Financial Insights, Recent Developments - Forecast To 2030
The global autoimmune disease diagnostics market is predicted to reach US$ 10.5 Billion by 2030. In June 2023, AstraZeneca signed an agreement with Quell Therapeutics potentially worth more than US$ 2 billion to develop cell therapies that could cure autoimmune diseases. As per the American Autoimmune Related Diseases Association, around 50 million Americans currently suffer from autoimmune related disorders.
Saudi Arabia In-Vitro Diagnostics (IVD) Market (By Technology, Application, Product, End User), Size, Share, Major Deals, Key Players Analysis, Recent Developments - Forecast To 2028
Saudi Arabia In-Vitro Diagnostics (IVD) market is predicted to reach US$ 1,176 Million by 2028. Saudi Arabian government is taking number of initiatives to improve the healthcare sector in the country. Under Vision 2030, the Saudi Arabian Government plans to invest over US$ 65 Billion to develop the country’s healthcare infrastructure. The government has set the target of privatizing 290 hospitals and 2,300 primary health centers by 2030.
Japan In-Vitro Diagnostics (IVD) Market (By Segment And Company), Size, Share, Major Deals, Trends And Recent Developments - Forecast To 2028
Japan In Vitro Diagnostics (IVD) market is predicted to surpass US$ 5.5 Billion by 2028. The population of Japan is aging rapidly. For instance, as of November 2022, close to 36.5 million people in Japan were estimated to be within the age group 65 and over. Thus, Japan’s quickly aging population leads to an explosion of chronic conditions such as heart disease and cancer.  All of these conditions can be diagnosed and monitored using IVD products.
China In-Vitro Diagnostics (IVD) Market (By Segment And Company), Size, Share, Regulations, Reimbursement, Major Deals, Trends & Recent Developments - Forecast To 2028
China In-Vitro Diagnostics (IVD) market is predicted to exceed US$ 25 Billion by 2028. Immunoassays accounted for lion’s share of the total China IVD market, and is likely to maintain its dominant position over the forecast period as well. Molecular Testing is the fastest growing segment of the China IVD market, driven by increasing demand for polymerase chain reaction (PCR) products in China.
South Korea In-Vitro Diagnostics (IVD) Market (By Technology, Application, Product, End User), Size, Share, Major Deals, Key Players Analysis, Government Initiatives, Recent Developments - Forecast To 2028
South Korea In-Vitro Diagnostics (IVD) market is predicted to reach US$ 3.7 Billion by 2028. The Korean ‘Act on In Vitro Diagnostic Medical Devices’ came into effect on May 1, 2020, presenting an independent legal foundation to reinforce the IVD industry by promoting advanced technology to be applied promptly. Further, owing to the vast opportunities in this region, key players are coming up with market development strategies to leverage it.Â
Global Point Of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact Of COVID-19, Recent Developments, Company Profiles - Forecast To 2028
The global point of care testing (POCT) market is predicted to reach nearly US$ 65 Billion by 2028. Point-of-care (POC) testing has skyrocketed in the last 20 years as demand for accurate and fast testing has blossomed both inside and outside the hospital setting. Based on diagnostics segment, the point of care testing market is dominated by blood glucose testing segment.

Global Food Safety Testing Market (by Contaminants, Pathogens, Type Of Food Tested, Technology/Method, Region), Impact Of COVID-19, Company Profiles, Major Acquisitions And Recent Developments - Forecast To 2028
The global food safety testing market is predicted to surpass US$ 32 Billion by 2028. Food-related queries and complaints are continuously rising, which reflects a growing concern of government authorities and consumers. Companies engaged in the manufacturing and distributions of food products are mandated by respective regional and international regulatory agencies to implement food safety testing and certification.

Autoimmune Disease Diagnostics Market (By Disease, Test Types, Region), Impact Of COVID-19, Key Company Profiles, Recent Developments - Global Forecast To 2028
The global autoimmune disease diagnostics market was valued around US$ 14 Billion in 2021. Manufacturers in the autoimmune disease diagnostics market are focusing on developing novel technologies for maximum testing within a minimum period. On the basis

Japan In-Vitro Diagnostics (IVD) Market, Impact Of COVID-19, Size, Share, Major Deals, Company Analysis, Trends And Recent Developments - Forecast To 2028
Japan In Vitro Diagnostics (IVD) market is predicted to reach nearly US$ 4.5 Billion by 2028. In 2020, the COVID-19 pandemic has restricted the growth of Japan IVD market, as routine procedures were delayed by social restrictions and other precautionary m

China In-Vitro Diagnostics (IVD) Market, Impact Of COVID-19, Size, Share, Regulations, Reimbursement, Major Deals, Key Players Analysis, Trends & Recent Developments - Forecast To 2028
China In-Vitro Diagnostics (IVD) market is predicted to reach US$ 21 Billion by 2028. In China, COVID–19 disease has infected around 147,437 people, and the death toll has reached 4,638. Maximum testing and quick hospitalization are key components for fla

Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Impact Of COVID-19, Initiatives, Funding, Major Deals, 35 Company Profiles And Recent Developments - Forecast To 2028
The global liquid biopsy market is predicted to reach US$ 9.53 Billion by 2028. The advantages of liquid biopsy over solid tumor biopsy, rising prevalence of cancer, increasing preference for non-invasive procedures and favorable government initiatives, are some of the factors expected to propel the growth of liquid biopsy market in the coming years.

Saudi Arabia In-Vitro Diagnostics (IVD) Market (By Technology/Technique, Application, End User), Impact Of COVID-19, Size, Share, Major Deals & Key Players Analysis - Forecast To 2027
Saudi Arabia In-Vitro Diagnostics (IVD) market is predicted to reach US$ 1,242 Million by 2027. The Saudi Ministry of Health plans an expenditure of approximately SAR 23 Billion on the new initiatives within the industry of healthcare. Saudi Arabia government has set the target of privatizing 295 hospitals by 2030, under the Saudi Vision 2030 Plan.